MedPath

Dialysate calcium study in alternate night nocturnal haemodialysis

Phase 4
Conditions
Dialysis
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12608000057381
Lead Sponsor
Monash Medical Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Subjects receiving renal replacement therapy in the form of haemodialysis at home, alternate night nocturnal haemoialysis (NHD) (3.5nights/week)

Subjects must be 18-80 years of age

Willingness to provide written informed consent

Exclusion Criteria

Subjects unable to give informed consent or whom have an expected life-span of less than 3 months

Subjects already scheduled to have a kidney transplant from a known living donor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath